{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:11:03Z","timestamp":1791522663216,"version":"4.3.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100030732","name":"MSD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.vaccine.2025.127398","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T02:40:21Z","timestamp":1750387221000},"page":"127398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Healthcare resource use and costs associated with episodes of laboratory confirmed invasive pneumococcal disease in adults in Finland 2016\u20132022"],"prefix":"10.1016","volume":"61","author":[{"given":"Maarit J.","family":"Korhonen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"P\u00f6lkki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veli-Jukka","family":"Anttila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Klemets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Essi J.","family":"Peltonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Purmonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minna","family":"Vehkala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenni","family":"Kononoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.127398_bb0005","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/S0140-6736(22)02185-7","article-title":"Antimicrobial Resistance Collaborators. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the global burden of disease study 2019","volume":"400","author":"GBD 2019","year":"2022","journal-title":"The Lancet"},{"key":"10.1016\/j.vaccine.2025.127398_bb0010","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41579-018-0001-8","article-title":"Streptococcus pneumoniae: transmission, colonization and invasion","volume":"16","author":"Weiser","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2025.127398_bb0015","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1136\/adc.2010.191718","article-title":"Invasive pneumococcal disease","volume":"96","author":"Randle","year":"2011","journal-title":"Arc Dis Child - Educ Pract Ed"},{"key":"10.1016\/j.vaccine.2025.127398_bb0020","series-title":"European Centre for Disease Prevention and Control. Invasive pneumococcal disease","author":"ECDC","year":"2018"},{"key":"10.1016\/j.vaccine.2025.127398_bb0025","author":"THL, Finnish Institute for Health and Welfare"},{"key":"10.1016\/j.vaccine.2025.127398_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0287378","article-title":"Invasive pneumococcal disease among the elderly in the later era of paediatric pneumococcal conjugate vaccination\u2014a longitudinal study over 10 years based on public surveillance data in the Nordics","volume":"18","author":"Palmborg","year":"2023","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2025.127398_bb0035","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1016\/j.vaccine.2022.08.047","article-title":"Long-term population impact of infant 10-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in adults in Finland","volume":"40","author":"Nuorti","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127398_bb0040","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","article-title":"Serotype replacement in disease after pneumococcal vaccination","volume":"378","author":"Weinberger","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2025.127398_bb0045","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.GPP3-0028-2018","article-title":"Pneumococcal vaccines","volume":"7","author":"Briles","year":"2019","journal-title":"Microbiol Spectr"},{"issue":"372","key":"10.1016\/j.vaccine.2025.127398_bb0050","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","article-title":"Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults","volume":"19","author":"Bonten","year":"2015","journal-title":"N Engl J Med"},{"issue":"e204","key":"10.1016\/j.vaccine.2025.127398_bb0055","first-page":"1","article-title":"Clinical and economic burden of pneumococcal disease among individuals aged 16 years and older in Germany","volume":"150","author":"Deb","year":"2022","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2025.127398_bb0060","series-title":"Terveydenhuollon yksikk\u00f6kustannukset 2017","author":"M\u00e4klin","year":"2020"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127398_bb0065","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S1473-3099(24)00344-X","article-title":"STRIDE-3 Study Group. Safety, tolerability, and immunogenicity of an adult pneumococcal conjugate vaccine, V116 (STRIDE-3): a randomised, double-blind, active comparator controlled, international phase 3 trial","volume":"24","author":"Platt","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127398_bb0070","author":"EMA, European Medicines Agency"},{"key":"10.1016\/j.vaccine.2025.127398_bb0075","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.3390\/vaccines9121380","article-title":"Economic burden of pneumococcal disease in individuals aged 15 years and older in the Liguria region of Italy","volume":"9","author":"Astengo","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2025.127398_bb0080","doi-asserted-by":"crossref","unstructured":"Vadlamudi NK, Sadatsafavi M, Patrick DM, Rose C, Hoang L, Marra F. Healthcare costs for pneumococcal disease in the era of infant immunization with 13-valent pneumococcal conjugate vaccine: a population-based study. Val Health 2022;25:1510\u20131519. https:\/\/doi.https:\/\/doi.org\/10.1016\/j.jval.2022.03.017.","DOI":"10.1016\/j.jval.2022.03.017"},{"key":"10.1016\/j.vaccine.2025.127398_bb0085","doi-asserted-by":"crossref","unstructured":"Mohanty S, Cossrow N, Yu KC, Ye G, White M, Gupta V, Clinical and economic burden of invasive pneumococcal disease and noninvasive all-cause pneumonia in hospitalized US adults: a multicenter analysis from 2015 to 2020. Int J Inf Dis 2024; 143:107023. https:\/\/doi: https:\/\/doi.org\/10.1016\/j.ijid.2024.107023.","DOI":"10.1016\/j.ijid.2024.107023"},{"key":"10.1016\/j.vaccine.2025.127398_bb0090","author":"THL, Finnish Institute for Health and Welfare"},{"key":"10.1016\/j.vaccine.2025.127398_bb0095","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S2213-2600(14)70139-0","article-title":"Vaccine effectiveness of the pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against clinically suspected invasive pneumococcal disease: a cluster-randomised trial","volume":"2","author":"Palmu","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.vaccine.2025.127398_bb0100","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41479-023-00110-y","article-title":"Acute organ injury and long-term sequelae of severe pneumococcal infections","volume":"15","author":"Kruckow","year":"2023","journal-title":"Pneumonia (Nathan)"},{"key":"10.1016\/j.vaccine.2025.127398_bb0105","author":"THL, Finnish Institute for Health and Welfare"},{"key":"10.1016\/j.vaccine.2025.127398_bb0110","author":"THL, Finnish Institute for Health and Welfare"},{"key":"10.1016\/j.vaccine.2025.127398_bb0115","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/thoraxjnl-2018-211767","article-title":"Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination","volume":"74","author":"Hanquet","year":"2019","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127398_bb0120","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3201\/eid2801.210734","article-title":"Serotype replacement after introduction of 10-valent and 13-valent pneumococcal conjugate vaccines in 10 countries","volume":"28","author":"Hanquet","year":"2022","journal-title":"Europe Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127398_bb0125","first-page":"1473","article-title":"Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): a global surveillance analysis","author":"Garcia Quesada","year":"2025","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127398_bb0130","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2279394","article-title":"Recent changes to adult national immunization programs for pneumococcal vaccination in Europe and how they impact coverage: a systematic review of published and grey literature","volume":"19","author":"Arya","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2025.127398_bb0135","author":"THL, Finnish Institute for Health and Welfare"},{"key":"10.1016\/j.vaccine.2025.127398_bb0140","author":"WHO, World Health Organization"},{"key":"10.1016\/j.vaccine.2025.127398_bb0145","unstructured":"Ahava M, Ilmavirta H, Hakanen A, Salmenlinna S, Gunell S, Aittoniemi J, et al. Bakteerien mikrobil\u00e4\u00e4keresistenssi Suomessa; Finres 2022. Finnish Institute for Health and Welfare. http:\/\/urn.fi\/URN:ISBN:978-952-408-187-0; 2023 [accessed 14 November 2024]."},{"key":"10.1016\/j.vaccine.2025.127398_bb0150","doi-asserted-by":"crossref","first-page":"eadf1093","DOI":"10.1126\/scitranslmed.adf1093","article-title":"Vaccines for a sustainable planet","volume":"15","author":"Pecetta","year":"2023","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2025.127398_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060273","article-title":"Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques","volume":"8","author":"Said","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2025.127398_bb0160","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1080\/14760584.2023.2261785","article-title":"Clinical, economic, and humanistic burden of community acquired pneumonia in Europe: a systematic literature review","volume":"22","author":"Tsoumani","year":"2023","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2025.127398_bb0165","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3109\/00365548.2013.876509","article-title":"Incidence and etiology of community-acquired pneumonia in the elderly in a prospective population-based study","volume":"46","author":"Palmu","year":"2014","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127398_bb0170","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/pds.3891","article-title":"International Society for Pharmacoepidemiology. Guidelines for good pharmacoepidemiology practices (GPP)","volume":"25","author":"Public Policy Committee","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25006954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25006954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T21:27:51Z","timestamp":1755898071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25006954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":34,"alternative-id":["S0264410X25006954"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127398","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Healthcare resource use and costs associated with episodes of laboratory confirmed invasive pneumococcal disease in adults in Finland 2016\u20132022","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127398","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Merck & Co., Inc., Rahway, NJ, USA and its affiliates and The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127398"}}